About Triomics
Triomics is a company based in San Francisco (United States) founded in 2020 by Hrituraj Singh and Sarim Khan. Triomics has raised $28.88 million across 3 funding rounds from investors including Nexus Venture Partners, Lightspeed India and General Catalyst. The company has 29 employees as of July 31, 2024. Triomics offers products and services including Trial Enrollment, Clinical Navigators, and Cancer Registries. Triomics operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter San Francisco, United States
- Employees 29 as on 31 Jul, 2024
- Founders Hrituraj Singh, Sarim Khan
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.88 M (USD)
in 3 rounds
-
Latest Funding Round
$15 M (USD), Series B
May 09, 2024
-
Investors
Nexus Venture Partners
& 3 more
-
Employee Count
29
as on Jul 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Triomics
Triomics offers a comprehensive portfolio of products and services, including Trial Enrollment, Clinical Navigators, and Cancer Registries.
Screens patients for ongoing clinical trials using generative AI.
Identifies eligible patients for trials and healthcare operations.
Manages oncology data for business intelligence and precision medicine.
Funding Insights of Triomics
Triomics has successfully raised a total of $28.88M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Triomics
Triomics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Nexus Venture Partners, Lightspeed India and General Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm that partners with entrepreneurs for product-first companies.
|
Locked | Locked | Locked | |
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Triomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Triomics
Investment portfolio details for Triomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Triomics
Detailed financials for Triomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Triomics Comparisons
Peer comparison for Triomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Triomics
Triomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
Detailed competitors of Triomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Triomics
Complete news archive for Triomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triomics
Triomics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Triomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Sarim Khan is the current CEO of Triomics. They have also founded this company.
Triomics is a funded company, having raised a total of $28.88M across 3 funding rounds to date.
As of Jul 31, 2024, the latest employee count at Triomics is 29.
Triomics was founded in 2020 in San Francisco, United States, within the health technology sector. An end-to-end platform is offered for managing clinical trials, where workflows for clinical care and research are integrated. Inefficiencies in data collection, patient recruitment, and related operational tasks are addressed through the software, supporting streamlined processes in clinical research operations.
Triomics offers Trial Enrollment, Clinical Navigators, and Cancer Registries.
Triomics has 4 investors. Key investors include Nexus Venture Partners, Lightspeed India, General Catalyst, and Y Combinator.